BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 28935471)

  • 1. Prevalence and decay of maternal pneumococcal and meningococcal antibodies: A meta-analysis of type-specific decay rates.
    Voysey M; Pollard AJ; Sadarangani M; Fanshawe TR
    Vaccine; 2017 Oct; 35(43):5850-5857. PubMed ID: 28935471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum, breast milk, and infant antibody after maternal immunisation with pneumococcal vaccine.
    Shahid NS; Steinhoff MC; Hoque SS; Begum T; Thompson C; Siber GR
    Lancet; 1995 Nov; 346(8985):1252-7. PubMed ID: 7475716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-stratified prevalences of pneumococcal-serotype-specific immunoglobulin G in England and their relationship to the serotype-specific incidence of invasive pneumococcal disease prior to the introduction of the pneumococcal 7-valent conjugate vaccine.
    Balmer P; Borrow R; Findlow J; Warrington R; Frankland S; Waight P; George R; Andrews N; Miller E
    Clin Vaccine Immunol; 2007 Nov; 14(11):1442-50. PubMed ID: 17881503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mother-infant vaccination with pneumococcal polysaccharide vaccine: persistence of maternal antibodies and responses of infants to vaccination.
    Holmlund E; Nohynek H; Quiambao B; Ollgren J; Käyhty H
    Vaccine; 2011 Jun; 29(28):4565-75. PubMed ID: 21550374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity and safety of CRM₁₉₇ conjugated 9-valent pneumococcal and meningococcal C combination vaccine in healthy infants.
    Mallet E; Brachet E; Fernsten P; Laudat F; Razmpour A; Gruber WC;
    Vaccine; 2011 Aug; 29(34):5812-9. PubMed ID: 21296118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity and safety of heptavalent conjugate vaccine against Streptococcus pneumoniae in pre-term Polish infants.
    Szynczewska E; Chlebna-Sokół D
    Vaccine; 2011 Sep; 29(40):7107-13. PubMed ID: 21803093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transplacental transmission of serotype-specific pneumococcal antibodies in a Brazilian population.
    Carvalho BT; Carneiro-Sampaio MM; Solé D; Naspitz C; Leiva LE; Sorensen RU
    Clin Diagn Lab Immunol; 1999 Jan; 6(1):50-4. PubMed ID: 9874663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different neisseria meningitidis serogroup C conjugate vaccines.
    Wysocki J; Tejedor JC; Grunert D; Konior R; Garcia-Sicilia J; Knuf M; Bernard L; Dieussaert I; Schuerman L
    Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S77-88. PubMed ID: 19325450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamics and Determinants of Pneumococcal Antibodies Specific against 13 Vaccine Serotypes in the Pre-Vaccination Era.
    Prins-van Ginkel AC; Berbers GA; Grundeken LH; Tcherniaeva I; Wittenberns JI; Elberse K; Mollema L; de Melker HE; Knol MJ
    PLoS One; 2016; 11(1):e0147437. PubMed ID: 26796783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal Immunization with Pneumococcal Polysaccharide Vaccine: Persistence of Maternal Antibodies in Infants.
    Berezin EN; Lopes CC; Cardoso MRA
    J Trop Pediatr; 2017 Apr; 63(2):118-123. PubMed ID: 27645456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional antibodies elicited by two heptavalent pneumococcal conjugate vaccines in the Finnish Otitis Media Vaccine Trial.
    Ekström N; Väkeväinen M; Verho J; Kilpi T; Käyhty H
    Infect Immun; 2007 Apr; 75(4):1794-800. PubMed ID: 17261612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of pneumococcal conjugate vaccine immunogenicity among infants and toddlers in an American Indian PnCRM7 efficacy trial.
    O'Brien KL; Moisi J; Moulton LH; Madore D; Eick A; Reid R; Weatherholtz R; Millar E; Hu D; Hackell J; Kohberger R; Siber G; Santosham M
    J Infect Dis; 2007 Jul; 196(1):104-14. PubMed ID: 17538890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomised, controlled trial of concomitant pneumococcal and meningococcal conjugate vaccines.
    Wysocki J; Tansey S; Brachet E; Baker S; Gruber W; Giardina P; Arora A
    Vaccine; 2010 Nov; 28(49):7779-86. PubMed ID: 20883736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticapsular serum antibody concentration and protection against pneumococcal colonization among children vaccinated with 7-valent pneumococcal conjugate vaccine.
    Millar EV; O'Brien KL; Bronsdon MA; Madore D; Hackell JG; Reid R; Santosham M
    Clin Infect Dis; 2007 May; 44(9):1173-9. PubMed ID: 17407035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Maternally Derived Anti-protein and Anticapsular IgG Antibodies on the Rate of Acquisition of Nasopharyngeal Carriage of Pneumococcus in Newborns.
    Ojal J; Goldblatt D; Tigoi C; Scott JAG
    Clin Infect Dis; 2018 Jan; 66(1):121-130. PubMed ID: 29020230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of an alternative reduced-dose infant schedule and a second year catch-up schedule with 7-valent pneumococcal conjugate vaccine on pneumococcal carriage: a randomized controlled trial.
    Dagan R; Givon-Lavi N; Porat N; Greenberg D
    Vaccine; 2012 Jul; 30(34):5132-40. PubMed ID: 22683519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Disribution of Streptococcus pneumoniae serotypes and serogroups among patients with invasive pneumococcal diseases in the Czech Republic in 1996-2003: background data for vaccination strategy].
    Motlová J
    Epidemiol Mikrobiol Imunol; 2005 Feb; 54(1):3-10. PubMed ID: 15807381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of a routine opsonophagocytosis assay to predict invasive pneumococcal disease efficacy of conjugate vaccine in children.
    Henckaerts I; Durant N; De Grave D; Schuerman L; Poolman J
    Vaccine; 2007 Mar; 25(13):2518-27. PubMed ID: 17034907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pneumococcal vaccines: mechanism of action, impact on epidemiology and adaption of the species.
    Pletz MW; Maus U; Krug N; Welte T; Lode H
    Int J Antimicrob Agents; 2008 Sep; 32(3):199-206. PubMed ID: 18378430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity and safety of a combination pneumococcal-meningococcal vaccine in infants: a randomized controlled trial.
    Buttery JP; Riddell A; McVernon J; Chantler T; Lane L; Bowen-Morris J; Diggle L; Morris R; Harnden A; Lockhart S; Pollard AJ; Cartwright K; Moxon ER
    JAMA; 2005 Apr; 293(14):1751-8. PubMed ID: 15827314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.